Pfizer receives FDA fast track designation for tafamidis for transthyretin cardiomyopathy

7th June 2017 Uncategorised 0

Pfizer

More: Pfizer receives FDA fast track designation for tafamidis for transthyretin cardiomyopathy
Source: MDlinx